Detail akcie OptiBiotix Health online

Business Summary: OptiBiotix Health Plc is a life sciences company. The Company is engaged in the development of microbial strains, compounds, and formulations, which are used as active ingredients and supplements. It is focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. It is also developing its own range of consumer supplements and health products. Its areas of focus include obesity, cardiovascular health, and diabetes. Its products include SlimBiome, CholBiome, SweetBiotix, WellBiome, OptiBiotics and SlimBiome X3. SlimBiome offers a natural, scientifically supported, non-pharmaceutical approach to reducing hunger and cravings. CholBiome contains Lactobacillus plantarum LPLDL as the only active ingredient, focusing on healthy cholesterol maintenance and delivering tangible health benefits. SweetBiotix is a zero or low-calorie, prebiotic, and a smarter alternative to sugar and existing sweeteners.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, OptiBiotix Health PLC revenues increased 34% to L1.2M. Net loss increased from L1.8M to L3.9M. Revenues reflect United States segment increase from L141K to L354K, Rest of world segment increase from L95K to L268K. Higher net loss reflects Nutraceutical Industry segment loss increase of 38% to L3.1M. Basic Earnings per Share excluding Extraordinary Items decreased from -L0.02 to -L0.04.